Greg Rhee

Assistant Professor of Medicine (Psychiatric Epidemiology) and Public Health (Health Policy and Management)


UConn Health: Community Medicine and Health Care

Research Interests

Greg Rhee, PhD, MSW, is a health services researcher, who specializes in population-based clinical outcomes research and health care policy. His research interests consist of: (1) psychiatric epidemiology of behavioral health, focused on late-life depression and opioid use disorder; (2) drug-related health services research; and (3) social gerontology. Methodologically, his expertise is grounded on population-based observational studies using large databases. In particular, he has experiences using national health and healthcare survey data (e.g., HRS, NAMCS/NHAMCS, NSDUH, and NHIS), and also has a number of experiences with federal or state administrative claims data (e.g., Medicare and Medicaid).

He has more than 40 peer-reviewed research articles appeared in notable medical and health services research journals, such as JAMA Internal Medicine, Journal of the American Geriatrics Society, Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, and Health Services Research. In addition, he has been a successful collaborator or co-investigator of multiple research projects funded by major federal agencies, including Agency for Healthcare Research and Quality (AHRQ), Centers for Medicare and Medicaid Services (CMS), Food and Drug Administration (FDA), and National Institutes of Health (NIH). He is an alumnus of the University of Chicago and Yale University.

His current research focuses on improving health and healthcare among marginalized populations by addressing disparities in healthcare.


PhD, University of Minnesota College of Pharmacy (Social and Administrative Sciences in
Pharmacy), 2017
Postdoctoral, Yale University School of Medicine (Geriatric Clinical Epidemiology), 2019

Recent Publications

Rhee TG, Capistrant BD, Schommer JC, Hadsall RS, & Uden DL. Effects of 2009 USPSTF
depression screening recommendation on diagnosing and treating mental health conditions in
older adults: A difference-in-differences analysis. Journal of Managed Care and Specialty
Pharmacy, 2018;24(8), 769-776. (PMID: 30058984) 2017 Impact Factor: 2.464

Rhee TG, Westberg SM, & Harris IM. Use of complementary and alternative medicine in older
adults with diabetes. Diabetes Care, 2018;41(6), e95-e96. (PMID: 29643060) 2016 Impact
Factor: 11.857

Rhee TG, Choi YC, Ouellet GM, & Ross JS. High-risk anticholinergic use among older adults in
office-based outpatient visits: National prescribing trends from 2006 to 2015. Journal of the
American Geriatrics Society, 2018;66(7), 1382-1387. (PMID: 29582410) 2016 Impact Factor:

Rhee TG, Marottoli RA, Van Ness PH, & Tinetti ME. Patterns and perceived benefits of
utilizing seven major complementary and health approaches in U.S. older adults. The Journals of
Gerontology, Series A: Biological Sciences and Medical Sciences, 2018;73(8), 1119-1124.
(PMID: 29718133) 2016 Impact Factor: 5.957

Rhee TG. Continuing versus new antidepressant use in older adults: U.S. prescribing trends
from 2006 to 2015. European Geriatric Medicine, 2018;9(4), 551-555. (PMID: 30524610) 2016
Impact Factor: 1.336

Rhee TG, & Rosenheck RA. Does improvement in symptoms and quality of life in chronic
schizophrenia reduce family caregiver burden? Psychiatry Research, 2019;271, 402-404. (PMID:
30530058) 2017 Impact Factor: 2.223

Rhee TG, & Rosenheck RA. Initiation of psychotropic prescriptions without a psychiatric
diagnosis: Rates, correlates, and national trends from 2006-2015. Health Services Research,
2019;54(1), 139-148. (PMID: 30334247) 2017 Impact Factor: 2.667

Rhee TG, & Rosenheck RA. Comparison of opioid use disorder among male veterans and nonveterans: Disorder rates, socio-demographics, co-morbidities, and quality of life. The American
Journal on Addictions, 2019;28(2), 92-100. (PMID: 30664282) 2017 Impact Factor: 2.129

Rhee TG, Marottoli RA, Van Ness PH, & Levy BR. Impact of perceived racism on healthcare
access among minority older adults. American Journal of Preventive Medicine, 2019;56(4), 580-
585. (PMID: 30772147) 2017 Impact Factor: 5.043

Rhee TG. Co-prescribing of benzodiazepines and opioids in older adults: Rates, correlates, and
national trends in the US. The Journals of Gerontology, Series A: Biological Sciences and
Medical Sciences, E-pub ahead of print. (PMID: 30561526) 2017 Impact Factor: 4.902

Rhee TG, Pawloski PA, & Parsons HM. Health-related quality of life among US adults with
cancer: Potential roles of complementary and alternative medicine for health promotion and
well-being. Psycho-Oncology, 2019;28(4), 896-902. (PMID: 30803097) 2017 Impact Factor:

Vijay A, Rhee TG, & Ross JS. U.S. prescribing trends of opioids, fentanyl and other pain
medications in office-based outpatient and emergency department visits from 2006 to 2015.
Preventive Medicine, 2019;123, 123-129. (PMID: 30894321) 2017 Impact Factor: 3.483

Rhee TG, & Rosenheck RA. Association of current and past opioid use disorders with health-related quality of life and employment among US adults. Drug and Alcohol Dependence,
Accepted. (PMID: TBA) 2017 Impact Factor: 3.332

Rhee TG, & Ross JS. Association between industry payments to physicians and gabapentinoid
prescribing. JAMA Internal Medicine, Accepted. (PMID: TBA) 2017 Impact Factor: 19.989

Rhee TG, & Rosenheck RA. Psychotropic polypharmacy reconsidered: Between-class
polypharmacy in the context of multimorbidity in the treatment of depressive disorders. Journal
of Affective Disorders. (PMID: TBA) 2017 Impact Factor: 3.786

Contact Information
Phone(860) 679-5487
Mailing Address263 Farmington Ave Farmington, Connecticut 06030 United States
CampusUConn Health (Farmington)